Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Cord Blood America announces highlights for 6-month period ended June 30, 2010

Cord Blood America announces highlights for 6-month period ended June 30, 2010

Clarient second-quarter net revenue increases 21% to $28.7 million

Clarient second-quarter net revenue increases 21% to $28.7 million

Intensive chemotherapy may benefit elderly patients with acute myeloid leukemia

Intensive chemotherapy may benefit elderly patients with acute myeloid leukemia

New test to predict suitable treatment for chronic myeloid leukemia patients

New test to predict suitable treatment for chronic myeloid leukemia patients

GSK awards NCCN $4 million grant for study of ofatumumab and pazopanib

GSK awards NCCN $4 million grant for study of ofatumumab and pazopanib

LLS collaborates with Shape Pharmaceuticals to advance treatment for CTCL

LLS collaborates with Shape Pharmaceuticals to advance treatment for CTCL

Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

Asuragen reports collaborative study results of advanced PCR-based molecular profiling of FMR1 gene

Asuragen reports collaborative study results of advanced PCR-based molecular profiling of FMR1 gene

British adults support removal of tobacco displays in shops, ban on cigarette vending machines: Survey

British adults support removal of tobacco displays in shops, ban on cigarette vending machines: Survey

Study focuses on health issues of PGDP workers

Study focuses on health issues of PGDP workers

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Bristol-Myers Squibb second-quarter net sales increase 2% to $4.8 billion

Bristol-Myers Squibb second-quarter net sales increase 2% to $4.8 billion

Alexion second-quarter non-GAAP net income increases 56% to $36.9 million

Alexion second-quarter non-GAAP net income increases 56% to $36.9 million

Researchers receive $780,000 to study estrogen levels, behavior of breast cancer tumors

Researchers receive $780,000 to study estrogen levels, behavior of breast cancer tumors

Genzyme second-quarter revenue decreases to $1.08 billion

Genzyme second-quarter revenue decreases to $1.08 billion

Genmab reports Arzerra net sales of DKK 73 million during second-quarter 2010

Genmab reports Arzerra net sales of DKK 73 million during second-quarter 2010

Abbott second-quarter global sales increase 17.8% to $8.8 billion

Abbott second-quarter global sales increase 17.8% to $8.8 billion

Opinions: AIDS vaccine and cure; China's role in the Global Fund; Child marriage prevention act; Gorbachev on safe water

Opinions: AIDS vaccine and cure; China's role in the Global Fund; Child marriage prevention act; Gorbachev on safe water

CHLA receives $410,000 grant for 'first in childhood leukemia' multi-site study

CHLA receives $410,000 grant for 'first in childhood leukemia' multi-site study

EntreMed regains compliance with NASDAQ $1.00 minimum closing bid price requirement

EntreMed regains compliance with NASDAQ $1.00 minimum closing bid price requirement

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.